Slower growth in Medicare spending is likely a result of more spending constraints rather than the recession.
NATIONAL REPORTS- Slower growth in Medicare spending is likely a result of more spending constraints rather than the recession.
"The elderly were not impacted in the same way as the non-elderly by the recession," says Chapin White, a Center for Studying Health System Change (HSC) senior health researcher. "Obviously, there wasn't the same loss of employment. Their incomes continued to increase in real terms."
But slower growth in Medicare spending is a trend, he says. The Congressional Budget Office (CBO) in January made a $69 billion downward revision to its 10-year Medicare spending projection.
"The effect of PPACA grows over time, because it basically said the increase in Medicare payment rates from 2011 to 2012 is going to be one percentage point lower than it would have been, and the same going from 2012 to 2013," White says. "So there's a bigger and bigger wedge that happens over time."
The recession may also be behind the increasing Medicare Advantage enrollment. January and February enrollment numbers released by the Centers for Medicare and Medicaid Services (CMS), show membership increased by 693,000 lives. As of February 1, total Medicare Advantage membership was more than 13 million lives, according to CMS data.
Seniors are looking for value in their health plans, according to Mary Kennedy, vice president, Medicare Programs at the Association for Community Affiliated Plans. Certain benefits, such as hearing aids for example, might be covered under Medicare Advantage Special Needs Plans.
FDA Site Inspections Decreased During Pandemic. Questions Continue about Drug Quality.
December 4th 2023A recent study has found that FDA inspections of drug manufacturing facilities have increased since the COVID-19 health emergency but have not yet returned to pre-pandemic numbers.
Read More
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
November 8th 2023Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen
RSV Vaccines for Adults: Gaps in Understanding
December 4th 2023Angela Branche, M.D., an infectious disease specialist at the University of Rochester School of Medicine, says the gaps are in a precise understanding of who is at risk for serious illness from respiratory syncytial virus and therefore who should get vaccinated.
Read More
Managing Editor of Managed Healthcare Executive, Peter Wehrwein, had a discussion with William Shrank, M.D., a venture partner with Andreessen Horowitz, a venture capital firm in Menlo Park, California, about how artificial intelligence's role is improving healthcare, where we are today with value-based care and the ongoing efforts of reducing waste in the healthcare space for this episode of the "What's on Your Mind" podcast series.
Listen